In context
Palmitoyl tripeptide-38 was included in a multi-ingredient moisturiser evaluated in an open-label study completed by 37 women. [1]
At a glance
- Type
- Topical cosmetic ingredient
- Regulatory context
- The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.
- Evidence
- There was no blinded placebo comparison in the cited study. Observed appearance changes cannot be assigned to this peptide alone.
How to interpret this evidence
There was no blinded placebo comparison in the cited study. Observed appearance changes cannot be assigned to this peptide alone. [1]
Safety and clinical context
Topical cosmetic research does not support injection or other systemic use. Safety and tolerability depend on the complete formulation and the person using it.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Primary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.